OrbiMed Israel GP Ltd. — SEC Form 4 filings
SEC reporting owner CIK 1569590. 5 Form 4 filings on record with FilingPulse; latest filed 2026-04-09.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-01-26 to 2026-04-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 2 filings — 8,125,000 shares, $12,500,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 5 legs across 2 filings — 129,002 shares, $684,127 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: purchase of 1,841,100 shares @ $2.40 ($4,418,640) in Adicet Bio, Inc., filed 2024-01-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Adicet Bio, Inc. (ACET) | 10% owner | 3 | 5 legs · 8,125,000 sh · $12,500,000 | 4 legs · 104,658 sh · $674,847 | — |
| BiomX Inc. (PHGE) | 10% owner | 2 | — | 1 leg · 24,344 sh · $9,280 | 4 |
Form 4 filings — OrbiMed Israel GP Ltd.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-09 | 4 | Adicet Bio, Inc. (ACET) jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC, OrbiMed Advisors Israel II Ltd, OrbiMed Israel GP II, L.P., OrbiMed Israel BioFund GP Limited Partnership | Sale (S): 29,319 @ $6.53 · Sale (S): 2,400 @ $6.38 · Sale (S): 32,523 @ $6.29 · Sale (S): 40,416 @ $6.52 | EDGAR |
| 2025-10-10 | 4 | Adicet Bio, Inc. (ACET) jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC, OrbiMed Advisors Israel II Ltd, OrbiMed Israel GP II, L.P., OrbiMed Israel BioFund GP Limited Partnership | Purchase (P): 1,500,000 @ $1 · Purchase (P): 3,500,000 @ $1 | EDGAR |
| 2024-05-20 | 4 | BiomX Inc. (PHGE) jointly with OrbiMed Israel BioFund GP Limited Partnership, GORDON CARL L, Chimovits Erez | Option exercise/expiry (X): 9,280,408 @ $0.24 · Sale (S): 24,344 @ $0.38 · Option exercise/expiry (X): 9,280,408 (derivative) @ $0 | EDGAR |
| 2024-03-19 | 4 | BiomX Inc. (PHGE) jointly with OrbiMed Israel BioFund GP Limited Partnership, GORDON CARL L, Chimovits Erez | Purchase (P): 4,327 (derivative) · Purchase (P): 2,163,500 (derivative) | EDGAR |
| 2024-01-26 | 4 | Adicet Bio, Inc. (ACET) jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC, OrbiMed Advisors Israel II Ltd, OrbiMed Israel GP II, L.P., OrbiMed Israel BioFund GP Limited Partnership | Purchase (P): 1,841,100 @ $2.40 · Purchase (P): 242,200 @ $2.40 · Purchase (P): 1,041,700 @ $2.40 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1569590 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →